Comments
Loading...

Passage Bio

PASGNASDAQ
Logo brought to you by Benzinga Data
$0.701000
-0.03-3.60%
At Close: -
$0.710000
0.00901.28%
After Hours: 6:08 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$13.00
Lowest Price Target1
$5.00
Consensus Price Target1
$8.00

Passage Bio (NASDAQ:PASG) Stock, Analyst Ratings, Price Targets, Forecasts

Passage Bio Inc has a consensus price target of $8 based on the ratings of 8 analysts. The high is $13 issued by Canaccord Genuity on May 15, 2024. The low is $5 issued by Raymond James on November 14, 2023. The 3 most-recent analyst ratings were released by Rodman & Renshaw, Canaccord Genuity, and Canaccord Genuity on September 3, 2024, May 15, 2024, and March 5, 2024, respectively. With an average price target of $11.33 between Rodman & Renshaw, Canaccord Genuity, and Canaccord Genuity, there's an implied 1496.24% upside for Passage Bio Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
May
0
0
0
0
Sep
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Rodman & Renshaw
Canaccord Genuity
Raymond James
Chardan Capital
Guggenheim

1calculated from analyst ratings

Analyst Ratings for Passage Bio

Data brought to you by Benzinga APIs

FAQ

Q

What is the target price for Passage Bio (PASG) stock?

A

The latest price target for Passage Bio (NASDAQ:PASG) was reported by Rodman & Renshaw on September 3, 2024. The analyst firm set a price target for $7.00 expecting PASG to rise to within 12 months (a possible 885.92% upside). 4 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Passage Bio (PASG)?

A

The latest analyst rating for Passage Bio (NASDAQ:PASG) was provided by Rodman & Renshaw, and Passage Bio initiated their buy rating.

Q

When was the last upgrade for Passage Bio (PASG)?

A

There is no last upgrade for Passage Bio

Q

When was the last downgrade for Passage Bio (PASG)?

A

The last downgrade for Passage Bio Inc happened on March 8, 2022 when JP Morgan changed their price target from N/A to N/A for Passage Bio Inc.

Q

When is the next analyst rating going to be posted or updated for Passage Bio (PASG)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Passage Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Passage Bio was filed on September 3, 2024 so you should expect the next rating to be made available sometime around September 3, 2025.

Q

Is the Analyst Rating Passage Bio (PASG) correct?

A

While ratings are subjective and will change, the latest Passage Bio (PASG) rating was a initiated with a price target of $0.00 to $7.00. The current price Passage Bio (PASG) is trading at is $0.71, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch